Thus, an explanation for the decreased levels of PON1 protein in HDL2 compared to HDL3 could be the increase of apoAII in CAD versus N subjects that favors PON1 displacement by MPO, which in turn oxidizes apoAI and weakens the PON1-apoAI link. This evidence concerns the gene PON1 and coronary artery disorder.